跳至主要内容
临床试验/CTRI/2018/02/011803
CTRI/2018/02/011803已完成未知

Effectiveness of 2% lignocaine medicated pad for reducing pain in patients during administration of Rabies immunoglobulin (RIG)

State Board of Medical Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult Patients (18 to 60 yrs) coming to the Preventive Clinic of Medical College, Thiruvananthapuram with Category III animal bites in whom Rabies Immunoglobulin (Equine Rabies immunoglobulin/Human Rabies Immunoglobulin) is adviced, with minimum 2 wounds on two different sites. Persons with more than 2 wounds will also be recruited and the most proximal and distal wound shall be taken for the study. One wound will be randomized to the intervention and the other to the placebo arm. Proximal wound is the wound closest to head and distal wound will be the one farthest from the head. In case of a wound on the face, proximity to an imaginary line drawn through the middle of the nose will be considered.

排除标准

  • Those who are not giving consent
  • Known Allergic to Lignocaine
  • History of contact dermatitis
  • Those with any contraindications to lignocaine
  • All mucosal exposures

研究者

发起方
State Board of Medical Research

相似试验